Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.

CONCLUSION: We observed an increase in OAA prevalence and the cost of oral targeted chemotherapy is high. Our findings underline the need for addressing these high-cost medications in future developments of a national drug program.
PMID: 33471346 [PubMed - as supplied by publisher]

Source: Canadian Journal of Public Health - January 20, 2021 Category: International Medicine & Public Health Authors: Leong C, Czaykowski P, Geirnaert M, Katz A, Dragan R, Yogendran M, Raymond C Tags: Can J Public Health Source Type: research